¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"partial agonist activity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® agonist ÇÑ±Û ÀÛ¿ëÁ¦, ÀÛ¿ë±Ù
¼³¸í   
  1. ¼ö¿ëü¿Í °áÇÕÇÏ¿© ÃÖ´ëÀÇ ¾à¸®ÀÛ¿ëÀ» ¹ßÇöÇϴ ȭÇй°ÁúÀ» ¸»ÇÑ´Ù. ¼ö¿ëü¿¡ Æ¯ÀÌÇϰԠģȭ¼ºÀ» °¡Áö°í ÀÖ´Ù. »ýü ¾È¿¡¼­ »ý»êµÇ´Â ³»ÀμºÀΠ°Í°ú »ýü ¹Û¿¡¼­ Åõ¿©µÇ´Â ¿ÜÀμºÀΠ°ÍÀÌ ÀÖ´Ù. ºÎºÐ ÀÛ¿ëÁ¦´Â ¼ö¿ëü¿Í °áÇÕÇØµµ 100%ÀÇ ¾à¸®ÀÛ¿ëÀ» ¹ßÇöÇÏÁö´Â ¾ÊÀ¸¸ç ¿ë·®À» Áõ°¡½ÃÄѵµ È¿°ú´Â Ä¿ÁöÁö ¾Ê´Â´Ù. 2. ÇغÎÇп¡¼­´Â ÁÖ°¡ µÇ¾î ¿òÁ÷À̴ ±ÙÀ°ÀÇ ¹«¸®
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • partial agonistic activity
    ºÎºÐÀÛ¿ëÁ¦È°¼º
  • agonist
    1. ÀÛ¿ëÁ¦ 2. ÀÛ¿ë±Ù
  • beta2-agonist
    º£Å¸2ÀÛ¿ëÁ¦
  • cholinergic agonist
    Äݸ°¼ºÀÛ¿ëÁ¦
  • dopamine agonist
    µµÆÄ¹ÎÀÛ¿ëÁ¦
  • GnRH agonist
    »ý½Ä»ùÀÚ±ØÈ£¸£¸ó¹æÃâÈ£¸£¸óÀÛ¿ëÁ¦
  • gonadotropin-releasing hormone agonist
    »ý½Ä»ùÀÚ±ØÈ£¸£¸ó¹æÃâÈ£¸£¸óÀÛ¿ëÁ¦
  • inverse agonist
    ¿ªÀÛ¿ëÁ¦
  • muscarinic agonist
    ¹«½ºÄ«¸°ÀÛ¿ëÁ¦
  • opioid agonist
    ¾ÆÆíÀ¯»çÀÛ¿ëÁ¦
  • antibacterial activity
    Ç×±ÕÀÛ¿ë
  • activity
    1. Ȱ¼ºµµ 2. Ȱµ¿, Ȱ¼º 3. -´É
  • biologic activity
    »ý¹°ÇÐÀûȰ¼º
  • caries activity
    ¿ì½ÄȰµ¿
  • electrical activity
    Àü±âȰ¼º
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gonadotropin releasing hormone agonist agonist
    »ý½Ä»ùÀÚ±ØÈ£¸£¸óºÐºñÈ£¸£¸óÀÛ¿ëÁ¦
  • activity
    Ȱ¼ºµµ, Ȱµ¿
  • specific activity
    ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
  • agonist
    1.ÀÛ¿ëÁ¦, 2.ÀÛ¿ë±Ù
  • beta2 agonist
    º£Å¸2ÀÛ¿ëÁ¦
  • dopamine agonist
    µµÆÄ¹ÎÀÛ¿ëÁ¦
  • GnRH agonist
    (¢¡gonadotropin releasing hormone agonist) »ý½Ä»ùÀÚ±ØÈ£¸£¸óºÐºñÈ£¸£¸óÀÛ¿ëÁ¦
  • partial denture
    ºÎºÐÀÇÄ¡, ºÎºÐƲ´Ï
  • partial gastrectomy
    ºÎºÐÀ§ÀýÁ¦¼ú
  • partial hydatidiform mole
    ºÎºÐÆ÷»ó±âÅÂ, ºÎºÐÆ÷µµ¼ÛÀ̱âÅÂ
  • partial pressure
    ºÐ¾Ð
  • complex partial seizure
    º¹ÇպκйßÀÛ
  • activated partial thromboplastin time
    Ȱ¼ºÈ­ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
  • partial thromboplastin time
    ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • partial agonistic activity
    ºÎºÐÈ¿´ÉȰ¼º
  • agonist
    ÀÛ¿ëÁ¦, ÀÛ¿ë±Ù
  • cholinergic agonist
    Äݸ°¼ºÃËÁøÁ¦
  • inverse agonist
    ¿ªÀÛ¿ëÁ¦
  • muscarinic agonist
    ¹«½ºÄ«¸°ÀÛ¿ëÁ¦
  • opioid agonist
    ¾ÆÆíÀ¯»çÀÛ¿ëÁ¦
  • activity
    Ȱ¼ºµµ, Ȱµ¿
  • activity therapist
    Ȱµ¿¿ä¹ý»ç, Ȱµ¿Ä¡·á»ç
  • activity therapy
    Ȱµ¿¿ä¹ý
  • antibacterial activity
    Ç×±ÕÀÛ¿ë
  • caries activity
    ¿ì½ÄȰµ¿¼º
  • electrical activity
    Àü±âȰµ¿
  • enzyme activity
    È¿¼ÒȰ¼º, È¿¼ÒȰ¼ºµµ
  • fibrinolytic activity
    ¼¶À¯¼Ò¿ëÇØ´É
  • helper cell activity
    µµ¿ò¼¼Æ÷´É, Á¶·Â¼¼Æ÷´É
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • GnRH agonist
    ¼º¼±ÀÚ±ØÈ£¸£¸ó À¯¸® È£¸£¸ó È¿´É¾à
  • alpha-adrenergic agonist
    ¾ËÆÄ¾Æµå·¹³¯¸°ÃËÁøÁ¦
  • PORP [=partial ossicular replacement prosthesis]
    À̼Ұñ ºÎºÐ ´ëÄ¡¹°
  • activated partial prothrombin time
    Ȱ¼º ºÎºÐÇÁ·ÎÆ®·Òºó½Ã°£
  • activated partial thromboplastin time
    Ȱ¼º ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
  • activated partial thromboplastin time =aPTT
    Ȱ¼ºÈ­ ºÎºÐ Æ®·Òº¸ÇÃ¶ó½ºÆ¾ ½Ã°£
  • free end saddle partial denture
    À¯¸®´Ü±¹ºÎÀÇÄ¡.
  • hepatoduodenal fold (partial)
    °£»ùâÀÚÁÖ¸§(ºÎºÐ)
  • horizontal partial laryngectomy
    ¼öÆòºÎºÐÈĵÎÀûÃâ¼ú
  • primitive duodenum (partial)
    ¿ø½Ã»ùâÀÚ (ºÎºÐ)
  • reaction of partial identity
    ºÎºÐÀÏÄ¡¹ÝÀÀ
  • SAR : structure activity relationship
    ±¸Á¶ÀÛ¿ë°ü°è.
  • activity
    Ȱ¼ºµµ(üÀàõöô), Ȱµ¿µµ(üÀÔÑöô), Ȱ¼º(üÀàõ).
  • activity
    ¹æ»ç´É, Ȱ¼ºµµ
  • activity therapist
    Ȱµ¿ ¿ä¹ý»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • partial agonist
    ºÎºÐÀû ÀÛ¿ë¾à(¡­íÂéÄå·).(¾à¸®)ºÎºÐ(Àû) È¿´É¾à, ºÎºÐ(Àû) È¿ÇöÁ¦.
  • partial agonistic activity
    ºÎºÐÈ¿´É(Àû) Ȱ¼º, ºÎºÐÈ¿Çö(Àû) Ȱ¼º.
  • adrenergic agonist
    ¾Æµå·¹³¯¸°¼ºÃËÁøÁ¦
  • agonist
    ÀÛ¿ëÁ¦(íÂéÄð¥), ÈïºÐÁ¦(ýéÝÇð¥)
  • agonist
    È¿´É¾à(üùÒöå·), È¿ÇöÁ¦(üùúéð¥).
  • alpha-adrenergic agonist
    ¾ËÆÄ¾Æµå·¹³¯¸°ÃËÁøÁ¦
  • cholinergic agonist
    Äݸ°¼º ÃËÁøÁ¦
  • dopamine agonist
    µµÆÄ¹Î È¿ÇöÁ¦(üùúÞð¥)
  • dopamine autoreceptor agonist
    µµÆÄ¹Î ÀÚ°¡¼ö¿ëü È¿ÇöÁ¦
  • inverse agonist
    ¿ª(¼º)È¿Çö<´É>Á¦.
  • muscarinic agonist
    ¹«½ºÄ«¸°¼ºÀÛ¿ëÁ¦
  • opioid agonist
    ¾ÆÆí¾çÀÛ¿ëÁ¦
  • activity
    ¹æ»ç´É, Ȱ¼ºµµ
  • activity
    Ȱ¼ºµµ(üÀàõöô), Ȱµ¿µµ(üÀÔÑöô), Ȱ¼º(üÀàõ).
  • activity therapist
    Ȱµ¿ ¿ä¹ý»ç
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Transverse colon (partial)
    °¡·ÎÁÖ¸§Ã¢ÀÚ [°¡·Î°áÀå] (ºÎºÐ)
    [¿¾ ¿ë¾î] ȾÇà°áÀå
  • Hepatoduodenal fold (partial)
    °£»ùâÀÚÁÖ¸§(ºÎºÐ)
    [¿¾ ¿ë¾î] °£½ÊÀÌÁöÀåÁÖ¸§
  • Pelvic diaphragm (partial)
    °ñ¹Ý°¡·Î¸·(ºÎºÐ)
    [¿¾ ¿ë¾î] °ñ¹ÝÁß°Ý
  • Male urethra (partial)
    ³²¼º¿äµµ(ºÎºÐ)
    [¿¾ ¿ë¾î] ³²¼º¿äµµ
  • Male vagina (partial)
    ³²¼ºÁú(ºÎºÐ)
    [¿¾ ¿ë¾î] ³²¼ºÁú
  • Definitive aortic arch (partial)
    ´ëµ¿¸ÆÈ°(ºÎºÐ)
    [¿¾ ¿ë¾î] ¿Ï¼º´ëµ¿¸Æ±Ã
  • Trapezius muscle (partial)
    µî¼¼¸ð±Ù (ºÎºÐ)
    [¿¾ ¿ë¾î] ½Â¸ð±Ù
  • Stapes(partial)
    µîÀÚ»À
    [¿¾ ¿ë¾î] µî°ñ
  • Sternocleidomastoid muscle (partial)
    ¸ñºø±Ù (ºÎºÐ)
    [¿¾ ¿ë¾î] Èä¼âÀ¯µ¹±Ù
  • Partial organ duplication (Bifurcated ureter)
    ºÎºÐ±â°üÁߺ¹ (¿ä°ü°¥¸²Áõ)
    [¿¾ ¿ë¾î] ºÎºÐ±â°üÁߺ¹ (¿ä°ü°¥¸²Áõ)
  • Partial inversion (Aorticopulmonary transposition)
    ºÎºÐÀÚ¸®¹Ù²Þ (´ëµ¿¸ÆÇãÆÄµ¿¸ÆÀÚ¸®¹Ù²Þ)
    [¿¾ ¿ë¾î] ºÎºÐÀû¿ªÀ§
  • Oblique vein (partial)
    ºøÁ¤¸Æ(ºÎºÐ)
    [¿¾ ¿ë¾î] »çÁ¤¸Æ
  • Duodenum (partial)
    »ùâÀÚ [½ÊÀÌÁöÀå] (ºÎºÐ)
    [¿¾ ¿ë¾î] ½ÊÀÌÁöÀå
  • Third ventricle (partial)
    ¼Â°³ú½Ç(ºÎºÐ)
    [¿¾ ¿ë¾î] Á¦»ï³ú½Ç
  • Internal iliac artery (partial)
    ¼Ó¾ûµ¢µ¿¸Æ(ºÎºÐ)
    [¿¾ ¿ë¾î] ³»Àå°ñµ¿¸Æ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • partial agonist
    ºÎºÐ ÀÛµ¿Á¦(Ý»ÝÂíÂÔÑð¥)
  • agonist
    ÀÛµ¿Ã¼ (íÂÔÑô÷)
  • cholinergic agonist
    Äݸ°ÀÛµ¿Á¦(íÂÔÑð¥)
  • partial digest
    ºÎºÐ ¼ÒÈ­¹°(Ý»ÝÂá¼ûùÚª)
  • partial hydrolysate
    ºÎºÐ °¡¼öºÐÇØ¹°(Ý»ÝÂÊ¥â©ÝÂú°Úª)
  • partial hydrolysis
    ºÎºÐ °¡¼öºÐÇØ(Ý»ÝÂÊ¥â©ÝÂú°)
  • partial inhibition
    ºÎºÐ ÀúÇØ(Ý»ÝÂîÁúª)
  • partial molar quantity
    ºÎºÐ(Ý»ÝÂ) ¸ô ·®(Õá)
  • partial pressure
    ºÐ¾Ð(ÝÂäâ)
  • partial reaction
    ºÎºÐ ¹ÝÀÀ(Ý»ÝÂÚãëë)
  • partial specific quantity
    Æíºñ·®(ø¶ÝïÕá)
  • partial specific volume
    Æíºñ¿ëÀû(ø¶Ýïé»îÝ)
  • reaction of partial identity
    ºÎºÐ µ¿Áú¼º(Ý»ÝÂÔÒòõàõ) ¹ÝÀÀ(Úãëë)
  • activity
    Ȱ·®(üÀÕá)
  • activity
    Ȱ¼º (üÀàõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activity
    Ȱ¼ºµµ, Ȱµ¿µµ
  • partial
    ºÎºÐ(Àû)ÀÇ, ºÒ¿ÏÀüÀÇ
  • partial ankylosis
    ºÎÀü°­Á÷
  • partial echo imaging
    ºÎºÐ¿¡ÄÚ ¿µ»ó
  • partial gastrectomy
    ºÎºÐÀû ÀýÁ¦
  • partial laminectomy
    ºÎºÐÃß±ÃÀýÁ¦¼ú
  • partial nephrectomy
    ºÎºÐ½ÅÀýÁ¦¼ú
  • partial PACS
    ºÎºÐÆÑ½º
  • partial saturation
    ºÎºÐÆ÷È­
  • partial saturation spin echo sequence
    ºÎºÐÆ÷È­½ºÇÉ¿¡ÄÚ¿¬¼â
  • partial saturation state
    ºÎºÐÆ÷È­»óÅÂ
  • partial splenic arterial embolization
    ºÎºÐÀûºñµ¿¸Æ»öÀü¼ú
  • partial volume
    ºÎºÐ¿ëÀû
  • partial volume averaging
    ºÎºÐ¿ëÀûÆò±ÕÈ­
  • partial volume effect
    ºÎºÐ¿ëÀûÈ¿°ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PAA partial agonist activity; phenylacetic acid; phosphonoacetic acid; physical abilities analysis; plas...
NYHA New York Heart Association
  Heart Disease¿¡ ´ëÇÑ Functional Classification
 &nbs...
PR by way of the rectum [Lat. per rectum]; far point [of accommodation] [Lat. punctum remotum]; palindr...
IHSS(= HCMP) Idiopathic Hypertrophic Subaortic Stenosis
  = Obstructive Idiopathic Hypertrophic Car...
ORA opiate receptor agonist
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
R,S receptor agonist
8-OH-DPAT 5-HT agonist 8-hydroxy-2-(di-n-propylamino) tetralin
8-OH-DPAT 5-HT(1A) receptor agonist, 8-hydroxy 2(di-n-propyl(amino)tetralin
(35)S Agonist-stimulated
GNRH-a GnRH agonist
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • partial agonistic activity
    ºÎºÐ È¿´É, ºÎºÐ È¿´ÉÀû Ȱ¼º, ºÎºÐ È¿ÇöÀû Ȱ¼º
  • 2-adrenergic agonist
    2-¾Æµå·¹³¯¸° ÀÛ¿ëÁ¦, 2-¾Æµå·¹³¯¸° ÀÛµ¿Á¦
  • adrenergic agonist
    ¾Æµå·¹³¯¸°¼º ÀÛµ¿¾à
    ¾Æµå·¹³¯¸°¼º ¼ö¿ëü¸¦ ÈïºÐ½ÃÅ´À¸·Î½á È¿°ú¸¦ ³ªÅ¸³»´Â ¾à¹°. ´ë°Ô ¾Æ¹Î È­ÇÕ¹°À̹ǷΠ±³°¨½Å°æ À¯»ç ¾Æ¹ÎÀ̶ó°íµµ ÇÑ´Ù.
  • agonist muscle
    µ¿±Ù±º, ÁÖµ¿±Ù
  • alpha 2 agonist clonidine
    ¾ËÆÄ 2 ÀÛµ¿ Ŭ·Î´Ïµò
  • dopamine autoreceptor agonist
    µµÆÄ¹Î ÀÚ°¡ ¼ö¿ëü È¿ÇöÁ¦
  • high-affinity agonist
    °íģȭ¼º ÀÛ¿ë ¹°Áú
  • opiate agonist alkaloid
    ¾ÆÆí¼º ÀÛµ¿ ¹°Áú ¾ËÄ«·ÎÀ̵å
  • altered cast partial denture impression
    ±¹¼Ò ÀÇÄ¡ ±â´É Àλó
    Á¶Á÷ ÁöÁö¸¦ ¾ò±â À§ÇÑ ±â´É ÀλóÀ¸·Î °¡Ã¶¼º ±¹¼Ò ÀÇÄ¡ÀÇ ±Ý¼Ó ±¸Á¶¹°À» ÀÌ¿ëÇÏ¿© °³ÀÎ Æ®·¹À̸¦ Á¦ÀÛÇÑ ÈÄ ÀÜÁ¸ Ä¡Á¶Á¦ ºÎÀ§ÀÇ ÀλóÀ» 䵿ÇÏ´Â ¹æ¹ý.
  • bilateral partial denture
    ¾çÃø¼º ±¹¼Ò ÀÇÄ¡
  • cantilever fixed partial denture
    ĵƿ·¹¹ö °íÁ¤¼º ±¹¼Ò ÀÇÄ¡
  • distal extension partial denture
    ¿ø½É ¿¬Àå ±¹ºÎ ÀÇÄ¡
    ¾çÃø ¶Ç´Â ÆíÃøÀ¸·Î ÈĹ濡 Áö´ëÄ¡°¡ ¾ø´Â ±¹¼Ò ÀÇÄ¡À̸ç À¯¸®´Ü ±¹¼Ò ÀÇÄ¡¿Í µ¿ÀÏÇÑ ¿ë¾îÀÌ´Ù.
  • fixed partial denture
    °íÁ¤¼º ±¹¼Ò ÀÇÄ¡
    °¡Ã¶¼º ±¹¼Ò ÀÇÄ¡¿Í »ó´ëµÇ´Â ¿ë¾î·Î¼­ ÀÇÄ¡°¡ Çѹø ¿Ï¼ºµÇ¸é Ä¡¾Æ¿¡ °ß°íÈ÷ ºÎÂøµÇ¾î ÀÇÄ¡ÀÇ ¿ªÇÒÀ» ´ÙÇÏ°Ô µÈ´Ù.
  • free end saddle partial denture
    À¯¸®´Ü ±¹ºÎ ÀÇÄ¡
    ¾Ç±ÃÀÇ ÈĹ濡 ÀÜÁ¸Ä¡°¡ ÆíÃø ¶Ç´Â ¾çÃø¼ºÀ¸·Î ¾øÀ» ¶§ Á¦ÀÛµÈ ±¹¼Ò ÀÇÄ¡ÀÌ´Ù.
  • Kennedy classification of removable partial dentures
    °¡Ã¶¼º ÀÇÄ¡ÀÇ Äɳ׵ð ºÐ·ù
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
opioid partial agonist <pharmacology> A compound that has an affinity for and stimulates physiologic activity at the same cell receptors as opioid agonists but that produces only a partial (i.e., submaximal) bodily response.
(16 Dec 1997)
agonist 1. <anatomy> A prime mover.
2. <pharmacology> A drug that has affinity for and stimulates physiologic activity at cell receptors normally stimulated by naturally occurring substances, thus triggering a biochemical response.
(18 Nov 1997)
calcium channel agonist <pharmacology> Agents that increase calcium influx into calcium channels of excitable tissues.
This causes vasoconstriction in vascular smooth muscle and/or cardiac muscle cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture.
(12 Dec 1998)
receptor agonist A substance that mimics a specificneurotransmitter, is able to attach to that neurotransmitter's receptor and thereby produces the same action that theneurotransmitter usually produces. Drugs are often designed as receptor agonists to treat a variety of diseases and disorders whenthe original chemical substance is missing or depleted.
(22 May 1997)
mixed opioid agonist-antagonist <pharmacology> A compound that has an affinity for two or more types of opioid receptors and blocks opioid effects on one receptor type while producing opioid effects on a second receptor type.
(13 Nov 1997)
muscarinic agonist Drugs that bind to and activate muscarinic cholinergic receptors (receptors, muscarinic). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate.
(12 Dec 1998)
histamine agonist Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically.
(12 Dec 1998)
opioid agonist <pharmacology> Any morphine-like compound that produces bodily effects including pain relief, sedation, constipation and respiratory depression.
(16 Dec 1997)
LH and RH agonist <pharmacology> Particular medications that act as potent inhibitors of gonadotrophin (testosterone) secretion. They act to inhibit the production of testosterone through a feedback mechanism on the pituitary gland. LH and RH agonists are useful in the treatment of prostate cancer.
(14 Oct 1997)
activity 1. The state of being active, the ability to produce some effect, the extent of some function or action.
2. <chemistry> A thermodynamic quantity that represents the effective concentration of a solute in a nonideal solution, if concentrations are replaced by activities, the equations for equilibrium constants, electrode potentials, osmotic pressure, boiling point elevation, freezing point depression and vapour pressures of volatile solutes are converted from approximations that hold only for dilute solutions to exact equations that hold for all concentrations. The activity is equal to the product of the concentration and the activity coefficient, a dimensionless number measuring deviation from nonideality. Symbol a.
The potential or true thermodynamic activity of a substance, as opposed to its molar concentration.
3. <radiobiology> The number of nuclear transitions or disintegrations occurring in a given quantity of radioactive material per unit time. The SI unit of activity is s-1. The special name for the unit of activity is becquerel (Bq). The previously used special unit of activity, curie (Ci), is being replaced by the becquerel. 1 Bq = 2.7 x E-11 Ci. 1 Ci = 3.7 x E10 Bq.
4. Optical activity.
(16 Dec 1997)
activity coefficient <chemistry> The factor by which the value of a concentration of a solute must be multiplied to determine its true thermodynamic activity.
(06 May 1997)
activity cycles Bouts of physical irritability or movement alternating with periods of quiescence. It includes biochemical activity and hormonal activity which may be cellular. These cycles are shorter than 24 hours and include sleep-wakefulness cycles and the periodic activation of the digestive system.
(12 Dec 1998)
activity, drug A measure of the physiological response a drug produces in the body. A less active drug produces less response (and visa versa).
(12 Dec 1998)
blocking activity The repression or elimination of electrical activity in the brain by the arrival of a sensory stimulus.
(05 Mar 2000)
blood bactericidal activity Native bactericidal property of blood due to normally occurring antibacterial substances such as beta lysin, leukin, etc.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • agonist
    ½Î¿ò(°æ±â)ÀÇ °¡´ãÀÚ;(¹®ÇÐ ÀÛǰÀÇ)ÁÖÀΰø;ÁÖµ¿(ÀÛµ¿)±Ù;ÀÛ¿ë(ÀÛµ¿)¾à(¹°Áú)
  • activity
    Ȱµ¿,Ȱ±â
  • activity
    Ȱµ¿;Ȱ¾à;Ȱ±â;ȰȲ;´Éµ¿¼º;Ȱµ¿¹üÀ§
  • crew activity planning
    (¿ìÁÖ¼± ºñÇàÁßÀÇ) ½Â¹«¿ø ÀÛ¾÷°èȹ
  • extracurricular activity
    °ú¿Ü Ȱµ¿;(¼Ó)ºÎÁ¤(ºÎµµ´ö)ÇàÀ§;¿Üµµ
  • extravehicular activity
    (¿ìÁÖÀÎÀÇ)¼±¿Ü Ȱµ¿
  • Partial Test Ban Treaty
    ºÎºÐÀû ÇÙ½ÇÇè ±ÝÁö Á¶¾à
  • partial
    ºÎºÐÀûÀÎ;ºÒ¿ÏÀüÇÑ;ƯÈ÷ ÁÁ¾ÆÇÏ´Â
  • partial differential
    Æí¹ÌºÐ
  • partial eclipse
    ºÎºÐ½Ä
  • partial fraction
    ºÎºÐ ºÐ¼ö 
  • partial product
    ºÎºÐÀû
  • partial tone
    ºÎºÐÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á